Advances in treating bronchopulmonary dysplasia

Area of Science:

• Neonatal Medicine
• Pediatric Pulmonology
• Critical Care

Background:

• Bronchopulmonary dysplasia (BPD) is a chronic respiratory condition affecting infants born prematurely.
• BPD leads to long-term morbidities, including impaired lung function and reduced exercise capacity.
• Optimal management strategies for evolving or established BPD are crucial.

Purpose of the Study:

• To review current respiratory support modalities for BPD.
• To evaluate established and novel pharmacological treatments for BPD.
• To provide expert opinion on the evidence base and future research directions.

Main Methods:

• Review of respiratory support techniques like proportional assist ventilation and neurally adjusted ventilatory assist.
• Assessment of pharmacological treatments, including diuretics and emerging stem cell therapies.
• Analysis of existing evidence and expert recommendations for clinical practice and research.

Main Results:

• Certain respiratory support modalities show short-term improvements in oxygenation.
• Many pharmacological treatments are used without robust evidence.
• Stem cell therapies demonstrate promising results in small case series.

Conclusions:

• Respiratory support modalities require further investigation in randomized controlled trials (RCTs).
• Evidence for routine pharmacological treatments is often limited.
• Larger RCTs are needed to evaluate the long-term efficacy of promising therapies like stem cells.